Dr. Marques : Comparison of visual outcomes of 2 diffractive trifocal intraocular lenses.


February 2015  Volume 41, Issue 2, Pages 354–363


As you will read it, results are of course better as compared to bifocal and are similar between 2 trifocal IOLs.
However, we can clearly see that defocus curve of FineVision (Group 1) is, at all distances, better than the one from At Lisa Tri (Group 2). The same for the contrast sensitivity and glares, FineVision gives better results than the At Lisa Tri.
To compare the visual outcomes after cataract surgery with bilateral implantation of 1 of 2 diffractive trifocal intraocular lenses (IOLs).

Two clinical centers, Lisbon, Portugal.

Prospective comparative case series.

Phacoemulsification with bilateral implantation of a Finevision Micro F IOL (Group 1) or an AT Lisa tri 839 MP IOL (Group 2) was performed. Over a 3-month follow-up, the main outcome measures were uncorrected distance visual acuity (UDVA), corrected monocular and binocular distance visual acuity, uncorrected intermediate visual acuity at 80 cm, distance-corrected intermediate visual acuity (DCIVA), uncorrected near visual acuity at 40 cm, distance-corrected near visual acuity (DCNVA), spherical equivalent (SE) refraction, defocus curves, contrast sensitivity, presence of dysphotopsia, and use of spectacles.

Each group comprised 30 eyes (15 patients). The mean values at 3 months were UDVA, 0.03 logMAR ± 0.08 (SD) (Group 1) and 0.08 ± 0.12 (Group 2) (P = .765); DCIVA, 0.04 ± 0.07 logMAR and 0.18 ± 0.18 logMAR, respectively (P = .048); DCNVA, 0.03 ± 0.06 logMAR and 0.11 ± 0.08 logMAR, respectively (P = .032); SE, −0.25 ± 0.30 diopter (D) and −0.02 ± 0.39 D, respectively (P = .087). There was no significant difference in contrast sensitivity or dysphotopic phenomena between groups.

Both trifocal IOL models provided excellent distance, intermediate, and near visual outcomes. Monocular DCIVA and DCNVA appeared slightly better in Group 1 (FineVision IOL). Predictability of the refractive results and optical performance were excellent, and all patients achieved spectacle independence.

Financial Disclosure
Neither author has a financial or proprietary interest in any material or method mentioned.

Volver a las noticias

En MEDICALMIX, SLU nos preocupa tu privacidad:

Las cookies son importantes para ti, influyen en tu experiencia de navegación, nos ayudan a proteger tu privacidad y permiten realizar las peticiones que nos solicites a través de la web. Nosotros usamos cookies analíticas, de personalización y publicitarias (propias y de terceros) que serán utilizadas con la finalidad de gestionar la web, recabar información sobre la utilización de la misma, realizar perfiles basados en tus hábitos de navegación y en el análisis de tu comportamiento dentro de nuestra web, mostrarte contenido útil y poder realizar mejoras. Si autorizas su instalación selecciona "Aceptar Cookies", de forma alternativa, puedes rechazar todas las cookies haciendo clic en el botón "rechazar" o si lo prefieres puedes configurar tus preferencias seleccionando "Configurar Cookies". También puedes consultar nuestra Política de Cookies y cambiar tus preferencias antes de otorgar o negar tu consentimiento.